Cognitive Function and Statin Administration During Doxorubicin-Based Cancer Treatment

1. The PREVENT trial assessed cognitive effects of atorvastatin during chemotherapy. 2. 238 patients with lymphoma or breast cancer were analyzed. 3. No significant cognitive decline was observed with atorvastatin. 4. Statin use showed potential improvement in executive function. 5. Study highlights the need for further exploration of statin benefits during chemotherapy.